LEGN

NASDAQStock

Legend Biotech Corporation

$19.25-1.01 (-4.98%)

52-Week Range

$16.65

$44.32

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.06

Volume

991.9K

Avg Volume

1.9M

Performance

+2.75%

-13.45%

-43.77%

YTD

-11.44%

-49.93%

-59.65%

-26.84%

Price Chart

ETF Exposure

LEGN is held by 53 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	21	$405	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	34	$667	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	41	$808	$81.7M	0.11%

PreviousPage 2 of 2

About LEGN ETF Exposure

Legend Biotech Corporation (LEGN) is held by 53 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $19.25. Investors can gain exposure to LEGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LEGN, sorted by portfolio weight.